ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment

n/a

Bibliographic Details
Published in:Annals of Oncology
Main Authors: D.M. Kowalski, N. Reinmuth, S.V. Orlov, J.R. Fischer, S. Sugawara, S. Mandziuk, D.M. Medine, S. Novello, Y. Takeda, R.A. Soo, K. Park, M. McCleod, S.L. Geater, M. Powell, R. May, P. Stockman, D. Planchard
Format: Article in Journal/Newspaper
Language:English
Published: 2018
Subjects:
Oncology
Hematology
Arctic
Online Access:https://www.openaccessrepository.it/record/45594
https://doi.org/10.1093/annonc/mdy292.001
id ftopenaccessrep:oai:zenodo.org:45594
record_format openpolar
spelling ftopenaccessrep:oai:zenodo.org:45594 2023-05-15T14:40:55+02:00 ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment D.M. Kowalski N. Reinmuth S.V. Orlov J.R. Fischer S. Sugawara S. Mandziuk D.M. Medine S. Novello Y. Takeda R.A. Soo K. Park M. McCleod S.L. Geater M. Powell R. May P. Stockman D. Planchard 2018-10-01 https://www.openaccessrepository.it/record/45594 https://doi.org/10.1093/annonc/mdy292.001 eng eng url:https://www.openaccessrepository.it/communities/itmirror https://www.openaccessrepository.it/record/45594 doi:10.1093/annonc/mdy292.001 info:eu-repo/semantics/openAccess Oncology Hematology info:eu-repo/semantics/article publication-article 2018 ftopenaccessrep https://doi.org/10.1093/annonc/mdy292.001 2022-11-23T06:45:32Z n/a Article in Journal/Newspaper Arctic Istituto Nazionale di Fisica Nucleare (INFN): Open Access Repository Arctic Annals of Oncology 29 viii493 viii494
institution Open Polar
collection Istituto Nazionale di Fisica Nucleare (INFN): Open Access Repository
op_collection_id ftopenaccessrep
language English
topic Oncology
Hematology
spellingShingle Oncology
Hematology
D.M. Kowalski
N. Reinmuth
S.V. Orlov
J.R. Fischer
S. Sugawara
S. Mandziuk
D.M. Medine
S. Novello
Y. Takeda
R.A. Soo
K. Park
M. McCleod
S.L. Geater
M. Powell
R. May
P. Stockman
D. Planchard
ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
topic_facet Oncology
Hematology
description n/a
format Article in Journal/Newspaper
author D.M. Kowalski
N. Reinmuth
S.V. Orlov
J.R. Fischer
S. Sugawara
S. Mandziuk
D.M. Medine
S. Novello
Y. Takeda
R.A. Soo
K. Park
M. McCleod
S.L. Geater
M. Powell
R. May
P. Stockman
D. Planchard
author_facet D.M. Kowalski
N. Reinmuth
S.V. Orlov
J.R. Fischer
S. Sugawara
S. Mandziuk
D.M. Medine
S. Novello
Y. Takeda
R.A. Soo
K. Park
M. McCleod
S.L. Geater
M. Powell
R. May
P. Stockman
D. Planchard
author_sort D.M. Kowalski
title ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
title_short ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
title_full ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
title_fullStr ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
title_full_unstemmed ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
title_sort arctic: durvalumab + tremelimumab and durvalumab monotherapy vs soc in ≥ 3l advanced nsclc treatment
publishDate 2018
url https://www.openaccessrepository.it/record/45594
https://doi.org/10.1093/annonc/mdy292.001
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_relation url:https://www.openaccessrepository.it/communities/itmirror
https://www.openaccessrepository.it/record/45594
doi:10.1093/annonc/mdy292.001
op_rights info:eu-repo/semantics/openAccess
op_doi https://doi.org/10.1093/annonc/mdy292.001
container_title Annals of Oncology
container_volume 29
container_start_page viii493
op_container_end_page viii494
_version_ 1766312768611287040

Similar Items